Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the effects of an investigational blood thinner, apixaban, in preventing venous thromboembolic (VTE) recurrence or death in patients with deep vein thrombosis ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
Collaborators
NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more
NCT06650826 · Arterial or Venous Thrombosis
NCT02650453 · Venous Thrombosis
NCT05588284 · Acute Deep Venous Thrombosis of Femoral Vein (Disorder)
NCT07329725 · Visceral Venous Thrombosis
Alabama Clinical Therapeutics, Llc
Birmingham, Alabama
Horizon Research Group, Inc.
Mobile, Alabama
Fort Smith Lung Center
Fort Smith, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions